Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-09 · accession 0001770252-21-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-12 | 2021-10-09 | MYGN | Lambert Nicole | See Remarks | F - Tax | $30.88 | -12.5K | 164.2K | -7% | -$385.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-09 | F | D | 5,013 | $30.88 | 171,639 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-09 | F | D | 7,470 | $30.88 | 164,169 | D | — | — |